Morgan Stanley analysts are betting big on brain-computer interface (BCI) technology as the hype continues to grow around the space. Kallum Titchmarsh, Adam Jonas, Patrick A. Wood, Drew Ranieri, Jakob Dodd, Roberto Valdes Sanchez Navarro and Justin X. Wang of Morgan Stanley recently released a report questioning if BCIs are “The Next Big MedTech Opportunity?” […]
paradromics
Another 5 brain-computer interface companies you should know
Over the past several months, there have been a number of significant developments in the brain-computer interface (BCI) space. The likes of Neuralink, Synchron and Precision Neuroscience, among others, continue to advance their platforms. Some even began clinical trials, while many more companies are vying to be the first to bring a BCI to market. […]
7 neurotech companies you need to know
Neurotech is going far beyond just using pacemaker-like devices to treat the brain and nervous system. In recent years, the tech has gotten smaller — and in some cases, even noninvasive. The hope is that the innovation will fuel wider adoption of technologies to treat everything from Alzheimer’s disease to anxiety. Plenty of major medical […]
FDA brings Paradromics BCI into advisory program
Brain-computer interface (BCI) developer Paradromics announced today that the FDA accepted it into its Total Product Life Cycle Advisory Program (TAP). TAP provides early and frequent strategic engagement from the FDA, patients, providers and payers. It facilitates rapid development and widespread access to medical devices. Paradromics can benefit from more timely premarket interactions, earlier identification and […]
Paradromics raises $33M, wins FDA breakthrough nod for brain-computer interface tech
Paradromics announced today that it raised $33 million in a Series A funding round and garnered an FDA breakthrough device designation. Austin, Texas-based Paradromics develops a high data-rate brain-computer interface (BCI). The company sees its latest financial and regulatory progress as a positive step into the competitive BCI market. Paradromics plans to use the funding […]
Brain-interface tech startup Paradromics raises $7m in seed funding
Medtech startup Paradromics said today it raised $7 million in seed round funding to help support its brain-machine interface technology intended to allow patients with severe connectivity disorders to operate advanced prosthetic devices. The San Jose, Calif.-based company is developing brain-machine interface tech intended to allow patients with disorders including blindness, deafness and paralysis to […]